Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer

BACKGROUND: By the traditional definition of unintended weight loss, cachexia develops in ~80% of patients with pancreatic ductal adenocarcinoma (PDAC). Here, we measure the longitudinal body composition changes in patients with advanced PDAC undergoing 5‐fluorouracil, leucovorin, irinotecan, and ox...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cachexia Sarcopenia Muscle
Asıl Yazarlar: Kays, Joshua K., Shahda, Safi, Stanley, Melissa, Bell, Teresa M., O'Neill, Bert H., Kohli, Marc D., Couch, Marion E., Koniaris, Leonidas G., Zimmers, Teresa A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6104116/
https://ncbi.nlm.nih.gov/pubmed/29978562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12307
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller